<学術雑誌論文>
Pharmacokinetic analysis based on dynamic contrast‐enhanced MRI for evaluating tumor response to preoperative therapy for oral cancer
作成者 | |
---|---|
本文言語 | |
出版者 | |
発行日 | |
収録物名 | |
巻 | |
号 | |
開始ページ | |
終了ページ | |
アクセス権 | |
権利関係 | |
関連DOI | |
関連URI | |
概要 | Purpose: To evaluate whether a pharmacokinetic analysis is useful for monitoring the response of oral cancer to chemoradiotherapy (CRT). Materials and Methods: Twenty-nine patients were included. Th...ey underwent dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) before and after CRT. The DCE-MRI data were analyzed using a Tofts and Kermode (TK) model. The histological evaluation of the effects of CRT was performed according to Ohboshi and Shimosato's classification. Results: None of the pre-CRT parameters were significantly different between the responders and nonresponders. The post-CRT volume of the extravascular extracellular space (EES) per unit volume of tissue (v_e) of responders (0.397 ± 0.080) was higher than that of nonresponders (0.281 ± 0.076) (P = 0.01). The change of the v_e between the pre- and post-CRT of the responders (0.154 ± 0.093) was larger than that of the nonresponders (0.033 ± 0.073) (P = 0.001). Therefore, the increase in the v_e strongly suggested a good tumor response to CRT, which reflected an increase of the EES secondary to the destruction of the cancer nest. The changes in the volume transfer constant (K^<trans>) were significantly different between the responders and nonresponders (P = 0.018). Conclusion: Both the increase of the ve and the elevation of permeability (K^<trans>) were indicative of a good tumor response to CRT. The pharmacokinetic analysis had potential for monitoring the histopathological response to CRT. J. Magn. Reson. Imaging 2012;36:589–597. © 2012 Wiley Periodicals, Inc.続きを見る |
詳細
PISSN | |
---|---|
EISSN | |
NCID | |
レコードID | |
主題 | |
タイプ | |
登録日 | 2024.08.08 |
更新日 | 2024.08.19 |